Company Filing History:
Years Active: 2021-2022
Title: Agnieszka Krzyzosiak: Innovator in Phosphatase Inhibitors
Introduction
Agnieszka Krzyzosiak is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biochemistry, particularly in the development of phosphatase inhibitors. With a total of four patents to her name, her work is paving the way for advancements in therapeutic applications.
Latest Patents
One of her latest patents is focused on methods for selecting phosphatase selective and non-selective phosphatase inhibitors. This invention discloses a method to discover selective inhibitors of phosphatases. The method involves screening a test compound to determine its binding affinity to different holophosphatases. The process includes providing two holophosphatases, testing a compound's ability to bind to each, and comparing the results to identify selective or non-selective binding. Another notable patent relates to inhibitors of PPP1 R15A and PPP1 R15B, which are crucial in treating diseases associated with misfolded proteins or proteostasis disorders. The compounds developed in this patent include specific formulas and their pharmaceutically acceptable salts.
Career Highlights
Agnieszka works at United Kingdom Research and Innovation, where she continues to push the boundaries of scientific research. Her innovative approaches have garnered attention in the scientific community, contributing to her reputation as a leading inventor in her field.
Collaborations
Agnieszka collaborates with esteemed colleagues such as Anne Bertolotti and Indrajit Das. These partnerships enhance her research and expand the impact of her inventions.
Conclusion
Agnieszka Krzyzosiak's work in phosphatase inhibitors exemplifies the intersection of innovation and therapeutic development. Her contributions are vital for advancing treatments for various diseases, showcasing her role as a key figure in modern biochemistry.